SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Stay informed with null’s coverage and analysis for Fortune.
Page 68 of 100
Health
As COVID cases spike, the EU introduces tough new vaccine export controls
By
David Meyer
and
Jeremy Kahn
Newsletters
The big question for Elon Musk and the bitcoin crowd
By
David Meyer
Newsletters
AT&T chair Bill Kennard: ‘Legacy businesses have to disrupt themselves’
By
David Meyer
and
Alan Murray
Newsletters
The future of collaboration
By
David Meyer
and
Alan Murray
Health
European stocks slip as coronavirus variants force retreat into lockdown
By
David Meyer
Newsletters
Friday feedback: Parsing the Danone drama
By
David Meyer
and
Alan Murray
Newsletters
CFO confidence is soaring
By
David Meyer
and
Alan Murray
Tech
France refuses to block Apple’s big privacy changes
By
David Meyer
Newsletters
Battle for the soul of capitalism
By
David Meyer
and
Alan Murray
International
‘A bitter failure’: Europe in turmoil over abrupt decision to halt the AstraZeneca COVID vaccine
By
Vivienne Walt
,
David Meyer
, and others
Newsletters
Starbucks CEO Kevin Johnson says the pandemic has strengthened the company
By
David Meyer
and
Alan Murray
Newsletters
America First is back—and it’s messing with the global rollout of Covid vaccines
By
David Meyer
Health
Novavax shares jump 20% after COVID-19 vaccine trial produces excellent results
By
David Meyer
Newsletters
Pfizer CEO Albert Bourla reflects on the pandemic’s anniversary
By
David Meyer
and
Alan Murray
Health
J&J’s COVID vaccine gets the all-clear in Europe—but an immediate rollout is unlikely
By
David Meyer